A Randomized, Double Blind, Vehicle-Controlled Multicenter Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA and Narrowband Red Light in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). J of Skin 2019, 3, S48. https://doi.org/10.25251/skin.3.supp.48.